Amedeo Smart

Free Medical Literature Service

 

Amedeo

HIV Infection
  Free Subscription

Articles published in
Int J Cancer
    November 2025
  1. GRABAR S, Lakrout P, Potard V, Belot A, et al
    Cancer risks and trends between 1997 and 2018, and effects of restored immunity in people living with HIV: Results from the ANRS CO4 French hospital database on HIV.
    Int J Cancer. 2025 Nov 20. doi: 10.1002/ijc.70253.
    >> Share

  2. NEWTON R, Tenet V, Mugisha J, Kimono B, et al
    Human papillomavirus infection and vaccination among young females in rural Uganda.
    Int J Cancer. 2025 Nov 6. doi: 10.1002/ijc.70227.
    >> Share

    October 2025
  3. ZHENG Y, Han J, Qu Y, Wang J, et al
    Circulating cell-free DNA methylation biomarkers for hepatocellular carcinoma risk prediction in HIV-positive Nigerian population.
    Int J Cancer. 2025 Oct 23. doi: 10.1002/ijc.70204.
    >> Share

  4. CHINULA L, Chagomerana MB, Mkochi T, Msowoya L, et al
    Single visit screen-triage-treat strategy using GeneXpert-based HPV testing of self-collected cervicovaginal samples and thermal ablation treatment for cervical cancer prevention among women in Lilongwe, Malawi.
    Int J Cancer. 2025 Oct 16. doi: 10.1002/ijc.70177.
    >> Share

  5. YU X, Nzoutchoum OL, Gao D, Hsu CD, et al
    Cervical cancer screening and prevalence among older US Medicare beneficiaries with and without HIV.
    Int J Cancer. 2025 Oct 13. doi: 10.1002/ijc.70193.
    >> Share

    September 2025
  6. LIU H, Zou Z, Zhang L
    Reply to 'Comments on "HPV vaccination is highly effective and cost-effective for cervical cancer prevention in women living with HIV in China: A cost-effectiveness analysis"'.
    Int J Cancer. 2025 Sep 9. doi: 10.1002/ijc.70129.
    >> Share

  7. LIU Z, Tong X
    Comments on "HPV vaccination is highly effective and cost-effective for cervical cancer prevention in women living with HIV in China: A cost-effectiveness analysis".
    Int J Cancer. 2025 Sep 9. doi: 10.1002/ijc.70130.
    >> Share

  8. SAEEDI E, Nemati S, Lotfi F, Domingues A, et al
    IRANCANSURV: A comprehensive analysis of childhood cancer survival in Iran.
    Int J Cancer. 2025 Sep 1. doi: 10.1002/ijc.70100.
    >> Share

    August 2025
  9. ZHAO J, Zhang Y, Li K, Xu L, et al
    Estimates of global, regional, and national incidence of Hodgkin lymphoma attributable to Human Immunodeficiency virus: A population attributable modeling study.
    Int J Cancer. 2025 Aug 29. doi: 10.1002/ijc.70115.
    >> Share

  10. FENG X, Patel EU, Kigozi G, Gravitt PE, et al
    Longitudinal patterns of penile human papillomavirus detection among Ugandan men: A prospective sampling study.
    Int J Cancer. 2025 Aug 25. doi: 10.1002/ijc.70107.
    >> Share

  11. HAAS CB, Ocampo R, Liu D, Zuniga M, et al
    Design and initial findings of a natural history study of anal HPV and associated lesions among young adult women in Costa Rica.
    Int J Cancer. 2025 Aug 15. doi: 10.1002/ijc.70082.
    >> Share

  12. LOPES-ARAUJO HF, Guimaraes RL, Carvalho-Silva WHV
    Correlations between new HIV infections and hospital admissions for non-Hodgkin lymphoma in Brazil.
    Int J Cancer. 2025 Aug 6. doi: 10.1002/ijc.70076.
    >> Share

  13. ROZEMEIJER K, Dias Goncalves Lima F, Kuyvenhoven EJ, de Vries HJC, et al
    Swab-based anal cancer screening in men living with HIV: Projected outcomes for different screening algorithms.
    Int J Cancer. 2025 Aug 5. doi: 10.1002/ijc.70046.
    >> Share

    July 2025
  14. BELLO-PEREZ M, Mascarell P, Fernandez-Gonzalez M, Garcia JA, et al
    ADAR1 mRNA quantification for predicting HSIL in persons with HIV and abnormal anal cytology.
    Int J Cancer. 2025 Jul 24. doi: 10.1002/ijc.70050.
    >> Share

    June 2025
  15. ZHENG Y, Han J, Qu Y, Wang J, et al
    DNA methylation biomarkers for cervical cancer risk prediction in HIV-positive Nigerian women.
    Int J Cancer. 2025 Jun 9. doi: 10.1002/ijc.35502.
    >> Share

  16. JENKINS M, Saidu R, Boa R, Mbatani N, et al
    Performance of thermoablation among women treated for high-risk human papillomavirus in a screen-and-treat program in South Africa.
    Int J Cancer. 2025 Jun 6. doi: 10.1002/ijc.35519.
    >> Share

    May 2025
  17. PISELLI P, Tavelli A, Cimaglia C, Muccini C, et al
    Cancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data.
    Int J Cancer. 2025 May 29. doi: 10.1002/ijc.35493.
    >> Share

    February 2025
  18. KEBEDE HB, Mekuria S, Asegid N, Forslund O, et al
    High-risk human papillomavirus genotypes in previously unscreened reproductive-age women in Ethiopia: A community-based cohort study.
    Int J Cancer. 2025 Feb 14. doi: 10.1002/ijc.35335.
    >> Share

    January 2025
  19. NALWOGA A, Jackson C, Fiorillo S, Manyeruke F, et al
    Evaluation of plasma alpha-1-antichymotrypsin as a marker for pulmonary Kaposi sarcoma.
    Int J Cancer. 2025 Jan 30. doi: 10.1002/ijc.35351.
    >> Share

    December 2024
  20. MOTLHALE M, Sitas F, de Villiers CB, Simba H, et al
    Smokeless tobacco (snuff) and site-specific cancer risks in adult Black South African women: Findings from the Johannesburg Cancer Study.
    Int J Cancer. 2024 Dec 16. doi: 10.1002/ijc.35293.
    >> Share

    November 2024
  21. LIU H, Zou M, Shen M, Kamarulzaman A, et al
    HPV vaccination is highly effective and cost-effective for cervical cancer prevention in women living with HIV in China: A cost-effectiveness analysis.
    Int J Cancer. 2024 Nov 17. doi: 10.1002/ijc.35242.
    >> Share

    September 2024
  22. DEBEAUDRAP P, Kabore FN, Setha L, Tegbe J, et al
    Performance of visual inspection, partial genotyping, and their combination for the triage of women living with HIV who are screen positive for human papillomavirus: Results from the AIMA-CC ANRS 12375 multicentric screening study.
    Int J Cancer. 2024 Sep 25. doi: 10.1002/ijc.35190.
    >> Share

    August 2024
  23. DUSINGIZE JC, Murenzi G, Muhoza B, Businge L, et al
    Cancer risk among people living with Human Immuodeficiency Virus (HIV) in Rwanda from 2007 to 2018.
    Int J Cancer. 2024 Aug 11. doi: 10.1002/ijc.35091.
    >> Share

    April 2024
  24. VASAVADA A, Stankiewicz Karita HC, Lin J, Schouten J, et al
    Methylation markers for anal cancer screening: A repeated cross-sectional analysis of people living with HIV, 2015-2016.
    Int J Cancer. 2024 Apr 29. doi: 10.1002/ijc.34977.
    >> Share

  25. DOWNHAM L, Rol ML, Forestier M, Romero P, et al
    Field experience with the 8-HPV-type oncoprotein test for cervical cancer screening among HPV-positive women living with and without HIV in LMICs.
    Int J Cancer. 2024 Apr 11. doi: 10.1002/ijc.34953.
    >> Share

  26. SINGINI MG, Muchengeti M, Sitas F, Chen WC, et al
    Antibodies against high-risk human papillomavirus proteins as markers for noncervical HPV-related cancers in a Black South African population, according to HIV status.
    Int J Cancer. 2024 Apr 5. doi: 10.1002/ijc.34919.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016